MaxCyte (MXCT) (MXCT)
:MXCT
Total Valuation
MaxCyte has a market cap or net worth of $76.60M. The enterprise value is $74.42M.
Market Cap$76.60M
Enterprise Value$74.42M
Share Statistics
MaxCyte has 106,674,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding106,674,010
Owned by Insiders1.42%
Owned by Institutions23.12%
Financial Efficiency
MaxCyte’s return on equity (ROE) is -0.26 and return on invested capital (ROIC) is -22.96%.
Return on Equity (ROE)-0.26
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-22.96%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee289.70K
Profits Per Employee-391.49K
Employee Count114
Asset Turnover0.16
Inventory Turnover0.82
Valuation Ratios
The current PE Ratio of MaxCyte is ―. MaxCyte’s PEG ratio is -0.48.
PE Ratio―
PS Ratio4.99
PB Ratio0.96
Price to Fair Value0.96
Price to FCF-4.56
Price to Operating Cash Flow-2.22
PEG Ratio-0.48
Income Statement
In the last 12 months, MaxCyte had revenue of 33.03M and earned -44.63M in profits. Earnings per share was -0.42.
Revenue33.03M
Gross Profit26.80M
Operating Income-43.55M
Pretax Income-44.63M
Net Income-44.63M
EBITDA-40.14M
Earnings Per Share (EPS)-0.42
Cash Flow
In the last 12 months, operating cash flow was -34.41M and capital expenditures -1.77M, giving a free cash flow of -36.18M billion.
Operating Cash Flow-34.41M
Free Cash Flow-36.18M
Free Cash Flow per Share-0.34
Dividends & Yields
MaxCyte pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change-73.77%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
MaxCyte upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MaxCyte as a current ratio of 8.30, with Debt / Equity ratio of 10.46%
Current Ratio8.30
Quick Ratio7.77
Debt to Market Cap<0.01
Net Debt to EBITDA0.05
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MaxCyte has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MaxCyte EV to EBITDA ratio is -4.06, with an EV/FCF ratio of -4.50.
EV to Sales4.93
EV to EBITDA-4.06
EV to Free Cash Flow-4.50
EV to Operating Cash Flow-4.73
Balance Sheet
MaxCyte has $103.04M in cash and marketable securities with $17.94M in debt, giving a net cash position of $85.10M billion.
Cash & Marketable Securities$103.04M
Total Debt$17.94M
Net Cash$85.10M
Net Cash Per Share$0.80
Tangible Book Value Per Share$1.61
Margins
Gross margin is 81.16%, with operating margin of -131.85%, and net profit margin of -135.14%.
Gross Margin81.16%
Operating Margin-131.85%
Pretax Margin-135.14%
Net Profit Margin-135.14%
EBITDA Margin-121.55%
EBIT Margin-137.12%
Analyst Forecast
The average price target for MaxCyte is $2.87, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.87
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―